Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System TechnologyROSELAND, N.J., April 01, 2024 (GLOBE NEWSWIRE) Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the year ending December 31, 2023. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved solid financial
ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) Milestone Scientific Inc. MLSS, a leading developer of computerized drug delivery instruments that provide…